m 8218 has been researched along with tert-butylhydroperoxide in 1 studies
| Studies (m 8218) | Trials (m 8218) | Recent Studies (post-2010) (m 8218) | Studies (tert-butylhydroperoxide) | Trials (tert-butylhydroperoxide) | Recent Studies (post-2010) (tert-butylhydroperoxide) |
|---|---|---|---|---|---|
| 118 | 24 | 80 | 2,272 | 3 | 575 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Y; Li, Y; Liu, Z; Yu, J; Yu, L | 1 |
1 other study(ies) available for m 8218 and tert-butylhydroperoxide
| Article | Year |
|---|---|
Penehyclidine hydrochloride inhibits renal ischemia/reperfusion-induced acute lung injury by activating the Nrf2 pathway.
Topics: Acute Lung Injury; Animals; Apoptosis; Disease Models, Animal; Gene Knockout Techniques; Humans; Kidney; Kidney Diseases; Lung; Macrophages, Alveolar; Male; NF-E2-Related Factor 2; Oxidative Stress; Quassins; Quinuclidines; Rats; Rats, Transgenic; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; tert-Butylhydroperoxide | 2020 |